版本:
中国

BRIEF-Immune Pharmaceuticals signs agreement to regain worldwide rights for Ceplene

June 15 Immune Pharmaceuticals Inc-

* Immune Pharmaceuticals signs agreement to regain worldwide rights for Ceplene

* Immune Pharmaceuticals Inc - under terms of acquisition agreement, immune has agreed to pay mylan a fixed price, which is payable in installments

* Immune Pharmaceuticals Inc - ‍cytovia intends to pursue continued development of ceplene towards potential regulatory approval in united states​

* Immune Pharmaceuticals - intends, through its immuno-oncology subsidary, cytovia inc to undertake commercialization efforts in europe, asia, latin america

* Immune Pharmaceuticals - assets acquired include rights to marketing authorizations, trademarks, patents, other intellectual property related to ceplene

* Immune Pharmaceuticals Inc - cytovia intends to pursue continued development of ceplene towards potential regulatory approval in united states Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐